Aminophospholipid glycation and its inhibitor screening system: A new role of pyridoxal 5′-phosphate as the inhibitor

Journal of Lipid Research

Volumn 47, Issue 5, 2006, Pages 964-974

  Higuchi, Ohki ^a   Nakagawa, Kiyotaka ^a   Tsuzuki, Tsuyoshi ^a   Suzuki, Toshihide ^b   Oikawa, Shinichi ^c   Miyazawa, Teruo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Diabetes; Lipid glycation inhibitor; Phosphatidylethanolamine

Indexed keywords

ADULT; ANIMALS; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIET; GLYCOLIPIDS; GLYCOSYLATION; HUMANS; MALE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PYRIDOXAL; PYRIDOXAL PHOSPHATE; RATS; TRIGLYCERIDES;

EID: 33646771683     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500348-JLR200     Document Type: Article

References (40)

1. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
2. Miyazawa, T. 1989. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic. Biol. Med. 7: 209-217.
3. Kinoshita, M., S. Oikawa, K. Hayasaka, A. Sekikawa, T. Nagashima, T. Toyota, and T. Miyazawa. 2000. Age-related increase in plasma phosphatidylcholine hydroperoxide concentrations in normal subjects and patients with hyperlipidemia. Clin. Chem. 46: 822-828.
4. Nagashima, T., S. Oikawa, Y. Hirayama, Y. Tokita, A. Sekikawa, Y. Ishigaki, R. Yamada, and T. Miyazawa. 2002. Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients. Diabetes Res. Clin. Pract. 56: 19-25.
5. Miyazawa, T., J. H. Oak, and K. Nakagawa. 2005. Tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma. Ann. N. Y. Acad. Sci. 1043: 280-283.
6. Nakagawa, K., J. H. Oak, O. Higuchi, T. Tsuzuki, S. Oikawa, H. Otani, M. Mune, H. Cai, and T. Miyazawa. 2005. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes. J. Lipid Res. 46: 2514-2524.
7. Oak, J. H., K. Nakagawa, and T. Miyazawa. 2000. Synthetically prepared Amadori-glycated phosphatidylethanolamine can trigger lipid peroxidation via free radical reactions. FEBS Lett. 481: 26-30.
8. Oak, J. H., K. Nakagawa, S. Oikawa, and T. Miyazawa. 2003. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells. FEBS Lett. 555: 419-423.
9. Oak, J. H., K. Nakagawa, and T. Miyazawa. 2002. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples. J. Lipid Res. 43: 523-529.
10. Folch, J., M. Lees, and G. H. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
11. Rose, H. G., and M. Oklander. 1965. Improved procedure for the extraction of lipids from human erythrocytes. J. Lipid Res. 6: 428-434.
12. Severin, E. S., N. N. Gulyaev, E. N. Khurs, and R. M. Khomotov. 1969. The synthesis and properties of phosphopyridoxyl amino acids. Biochem. Biophys. Res. Commun. 35: 318-323.
13. 6: determination of pyridoxal 5′-phosphate and 4-pyridoxic acid in human serum by reversed-phase high-performance liquid chromatography with chlorite postcolumn derivatization. Anal. Biochem. 333: 336-344.
14. Rojas, A., and M. A. Morales. 2004. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 76: 715-730.
15. Shapiro, R., M. J. McManus, C. Zalut, and H. F. Bunn. 1980. Sites of nonenzymatic glycosylation of human hemoglobin A. J. Biol. Chem. 255: 3120-3127.
16. Day, J. F., S. R. Thorpe, and J. W. Baynes. 1979. Nonenzymatically glucosylated albumin: in vitro preparation and isolation from normal human serum. J. Biol. Chem. 254: 595-597.
17. Ahmed, M. U., E. Brinkmann-Frye, T. P. Degenhardt, S. R. Thorpe, and J. W. Baynes. 1997. N-(Carboxyethyl)lysine, a product of chemical modification of protein by methylglyoxal, increases with age in human lens proteins. Biochem. J. 324: 565-570.
18. Vishwanath, V., K. E. Frank, C. A. Elmets, P. J. Dauchot, and V. M. Monnier. 1986. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes. 35: 916-921.
19. Baynes, J. W., and S. R. Thorpe. 2000. Glycoxidation and lipoxidation in atherogenesis. Free Radic. Biol. Med. 28: 1708-1716.
20. Jakus, V., and N. Rietbrock. 2004. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol. Res. 53: 131-142.
21. Bucala, R., Z. Makita, T. Koschinsky, A. Cerami, and H. Vlassara. 1993. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA. 90: 6434-6438.
22. Ravandi, A., A. Kuksis, L. Marai, and J. J. Myher. 1995. Preparation and characterization of glucosylated aminoglycerophospholipids. Lipids. 30: 885-891.
23. Tessier, F., and I. B. Aragon. 1998. Effect of pH, phosphate and copper on the interaction of glucose with albumin. Glycoconj. J. 15: 571-574.
24. Watkins, N. G., C. I. Neglia-Fisher, D. G. Dyer, S. R. Thorpe, and J. W. Baynes. 1987. Effect of phosphate on the kinetics and specificity of glycation of protein. J. Biol. Chem. 262: 7207-7212.
25. Burton, H. S., and D. J. McWeeny. 1963. Non-enzymic browning reactions: consideration of sugar stability. Nature. 197: 266-268.
26. Monnier, V. M. 2003. Intervention against the Maillard reaction in vivo. Arch. Biochem. Biophys. 419: 1-15.
27. Brownless, M. 1994. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes. 43: 836-841.
28. Metz, T. O., N. L. Alderson, M. E. Chachich, S. R. Thorpe, and J. W. Baynes. 2003. Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications. J. Biol. Chem. 278: 42012-42019.
29. Heath, M.M., K. C. Rixon, and J. J. Harding. 1996.Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, α-crystallin. Biochim. Biophys. Acta. 1315: 176-184.
30. Hipkiss, A. R., J. Michaelis, and P. Syrris. 1995. Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross- linking agent. FEBS Lett. 371: 81-85.
31. Percudani, R., and A. Peracchi. 2003. A genomic overview of pyridoxal-phosphate-dependent enzymes. EMBO Rep. 4: 850-854.
32. rd edition. R. B. Rucker, J. W. Suttie, D. B. McCormick, and L. J. Machlin, editors. Marcel Dekker, New York. 339-396.
33. 6 and risk of myocardial infarction in US physicians. J. Am. Coll. Nutr. 15: 136-143.
34. 6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am. J. Clin. Nutr. 73: 759-764.
35. 6 in BALB/c mice. J. Natl. Cancer Inst. 78: 951-959.
36. Monnier, V. M. 1989. Toward a Maillard reaction theory of aging. Prog. Clin. Biol. Res. 304: 1-22.
37. Ravandi, A., A. Kuksis, L. Marai, J. J. Myher, G. Steiner, G. Lewisa, and H. Kamido. 1996. Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood. FEBS Lett. 381: 77-81.
38. Pamplona, R., M. J. Bellmunt, M. Portero, D. Riba, and J. Prat. 1995. Chromatographic evidence for Amadori product formation in rat liver aminophospholipids. Life Sci. 57: 873-879.
39. Breitling-Utzmann, C. M., A. Unger, D. A. Friedl, and M. O. Lederer. 2001. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes: influence of glycation products on lipid peroxidation. Arch. Biochem. Biophys. 391: 245-254.
40. Ravandi, A., A. Kuksis, and N. A. Shaikh. 2000. Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20: 467-477.